NCT02773849 2024-07-29ADSTILADRIN (=INSTILADRIN) in Patients With High-Grade, Bacillus Calmette-Guerin (BCG) Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)Ferring PharmaceuticalsPhase 3 Completed157 enrolled 22 charts 1 FDA